NCT06910163View on ClinicalTrials.gov

Direct-to-angio Approach From loCal hOspitals Based on a PoInt-of-care bLOod Test for LVO

NANot yet recruitingINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2028

Conditions
Acute Stroke
Interventions
DIAGNOSTIC_TEST

Diagnostic standard of care

Participants will receive the diagnostic standard of care: standard laboratory workup, non-contrast brain CT, brain CTA, brain CTP, or brain MRI.

DIAGNOSTIC_TEST

LVOne Test

Participants will receive the LVOne test, which will measure D-dimer and Glial Fibrillary Acidic Protein (GFAP) levels to diagnose acute stroke.

Trial Locations (1)

00725

Hospital Menonita Caguas, Caguas

All Listed Sponsors
collaborator

University of Puerto Rico

OTHER

collaborator

Mennonite Health System

UNKNOWN

lead

Juan Vicenty

OTHER

NCT06910163 - Direct-to-angio Approach From loCal hOspitals Based on a PoInt-of-care bLOod Test for LVO | Biotech Hunter | Biotech Hunter